Literature DB >> 1720592

Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells.

J Fantini1, S Baghdiguian, N Yahi, J C Chermann.   

Abstract

We have used HIV1-NDK-infected HT29 cells grown on permeable substratum to study the polarity of virus maturation in human intestinal cells. When cultured in glucose-containing medium, these cells are mostly undifferentiated. The removal of glucose from the medium allowed the emergence of a selected differentiated subpopulation which continued to produce viral particles in the culture supernatant. The polarity of viral production was evaluated by harvesting virus from the two sides of the monolayer. Seventy-five percent of released HIV was found on the basolateral side of the monolayer. Mature viral particles were observed by electron microscopy near the apical (luminal) and the basolateral (serosal) membrane. These data suggest that epithelial cells of the colon productively infected by a selected strain of HIV are able to produce the virus through both sides of the epithelium but mainly through the serosal side.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720592     DOI: 10.1016/0042-6822(91)90570-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells.

Authors:  R Lodge; J P Lalonde; G Lemay; E A Cohen
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

2.  Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus.

Authors:  N Jourdan; M Maurice; D Delautier; A M Quero; A L Servin; G Trugnan
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein.

Authors:  R Lodge; L Delamarre; J P Lalonde; J Alvarado; D A Sanders; M C Dokhélar; E A Cohen; G Lemay
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal.

Authors:  Rosalia Mora; Enrique Rodriguez-Boulan; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission.

Authors:  J Deschambeault; J P Lalonde; G Cervantes-Acosta; R Lodge; E A Cohen; G Lemay
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Lymphocyte-facilitated infection of epithelia by human T-cell lymphotropic virus type I.

Authors:  V R Zacharopoulos; M E Perotti; D M Phillips
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus.

Authors:  R Pearce-Pratt; D Malamud; D M Phillips
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells.

Authors:  N Yahi; S Baghdiguian; H Moreau; J Fantini
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission.

Authors:  X Tan; R Pearce-Pratt; D M Phillips
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium.

Authors:  N Yahi; S Baghdiguian; J Fantini
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.